Ping Cheng
Impact in
- Hepatology top 5%
- Liver physiology and pathology
- Liver Disease and Transplantation
- Liver Diseases and Immunity
- Biochemistry top 5%
Papers in
- Epidemiology 14
- Liver Disease Diagnosis and Treatment 8
- Autophagy in Disease and Therapy 4
-
- Wnt/β-catenin signaling in development and cancer 4
- Heme Oxygenase-1 and Carbon Monoxide 3
- Peroxisome Proliferator-Activated Receptors 3
- Co-authors
- Chuanyong Guo (22 shared papers)Weiqi Dai (20 shared papers)Miao Shen (18 shared papers)Jie Lu (17 shared papers)Yingqun Zhou (14 shared papers)Chengfen Wang (15 shared papers)Kan Chen (14 shared papers)Ling Xu (10 shared papers)
- Journals
- PLoS ONE (5 papers)PPAR Research (3 papers)Biochemical and Biophysical Research Communications (2 papers)Molecular Carcinogenesis (1 paper)Drug Design Development and Therapy (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Ping Cheng
25 papers receiving 1.1k citations
Ping Cheng's Hit Papers
Peers
Comparison fields: 5 of 95
- Hepatology 216
- Biochemistry 88
- Clinical Biochemistry 70
- Cancer Research 147
- Epidemiology 319
Countries citing papers authored by Ping Cheng
This map shows the geographic impact of Ping Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Cheng more than expected).
Fields of papers citing papers by Ping Cheng
This network shows the impact of papers produced by Ping Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Cheng. The network helps show where Ping Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Ping Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 101 | |
| 2 | 2014 | 101 | |
| 3 | 2014 | 92 | |
| 4 | 2013 | 76 | |
| 5 | 2014 | 70 | |
| 6 | 2014 | 58 | |
| 7 | 2014 | 57 | |
| 8 | 2008 | 56 | |
| 9 | 2013 | 55 | |
| 10 | 2021 | 52 | |
| 11 | 2014 | 48 | |
| 12 | 2014 | 38 | |
| 13 | 2013 | 37 | |
| 14 | 2014 | 36 | |
| 15 | 2013 | 36 | |
| 16 | 2014 | 32 | |
| 17 | 2014 | 28 | |
| 18 | 2015 | 23 | |
| 19 | 2014 | 22 | |
| 20 | 2013 | 21 |
About Ping Cheng
Ping Cheng is a scholar working on Epidemiology, Molecular Biology, Oncology, Hepatology and Cancer Research, having authored 27 papers that have together received 1.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (8 papers), Wnt/β-catenin signaling in development and cancer (4 papers), Cancer Cells and Metastasis (4 papers), Autophagy in Disease and Therapy (4 papers), Advanced Glycation End Products research (3 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Hepatology (216 citations), Biochemistry (88 citations), Clinical Biochemistry (70 citations), Cancer Research (147 citations) and Epidemiology (319 citations). Ping Cheng has collaborated with scholars based in China and United States. Frequent co-authors include Chuanyong Guo, Weiqi Dai, Miao Shen, Jie Lu, Yingqun Zhou, Chengfen Wang, Kan Chen, Ling Xu, Jingjing Li and Fan Wang. Their work appears in journals such as PLoS ONE, PPAR Research, Biochemical and Biophysical Research Communications, Molecular Carcinogenesis and Drug Design Development and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.